Peter Brams
Impact in
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Immunology 15
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 4
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Ivor Royston (6 shared papers)Mogens H. Claësson (2 shared papers)Michael G. Malkowski (1 shared paper)Lei Xie (1 shared paper)W. Robert Bishop (1 shared paper)Wai Lam W. Ling (1 shared paper)Robert L. Shields (1 shared paper)Kandasamy Hariharan (2 shared papers)
- Journals
- The Journal of Immunology (3 papers)Cancer Research (2 papers)Human Antibodies (2 papers)Molecular Cancer Therapeutics (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- United StatesDenmarkLebanon
In The Last Decade
Peter Brams
20 papers receiving 341 citations
Peers
Comparison fields: 5 of 52
- Immunology 135
- Radiology, Nuclear Medicine and Imaging 112
- Endocrinology, Diabetes and Metabolism 72
- Immunology and Allergy 22
- Cancer Research 40
Countries citing papers authored by Peter Brams
This map shows the geographic impact of Peter Brams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Brams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Brams more than expected).
Fields of papers citing papers by Peter Brams
This network shows the impact of papers produced by Peter Brams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Brams. The network helps show where Peter Brams may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Brams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 144 | |
| 2 | 2000 | 43 | |
| 3 | 2001 | 36 | |
| 4 | 2018 | 27 | |
| 5 | T-cell activation. I. Evidence for a functional linkage between class I MHC antigens and the Tc-Ti complex. | 1989 | 24 |
| 6 | 1991 | 15 | |
| 7 | 1998 | 14 | |
| 8 | 1998 | 11 | |
| 9 | 1993 | 8 | |
| 10 | 1999 | 7 | |
| 11 | 1999 | 6 | |
| 12 | 1987 | 6 | |
| 13 | 1993 | 6 | |
| 14 | In vitro priming of human lymphocytes. I. IL-2 and IL-4 requirements. | 1993 | 6 |
| 15 | 1990 | 5 | |
| 16 | 1987 | 5 | |
| 17 | 1993 | 4 | |
| 18 | 2010 | 3 | |
| 19 | 1985 | 1 | |
| 20 | 2022 | 1 |
About Peter Brams
Peter Brams is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Infectious Diseases and Oncology, having authored 20 papers that have together received 372 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers), RNA Interference and Gene Delivery (2 papers), Respiratory viral infections research (2 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Immunology (135 citations), Radiology, Nuclear Medicine and Imaging (112 citations), Endocrinology, Diabetes and Metabolism (72 citations), Immunology and Allergy (22 citations) and Cancer Research (40 citations). Peter Brams has collaborated with scholars based in United States, Denmark and Lebanon. Frequent co-authors include Ivor Royston, Mogens H. Claësson, Michael G. Malkowski, Lei Xie, W. Robert Bishop, Wai Lam W. Ling, Robert L. Shields, Kandasamy Hariharan, Yan Wang and Leonard G. Presta. Their work appears in journals such as The Journal of Immunology, Cancer Research, Human Antibodies, Molecular Cancer Therapeutics and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.